U.S. District Judge F. Dennis Saylor IV said that claims about the Zofran’s labeling are sufficiently specific to pass muster. Read more
The lawsuit claimed that GSK knew about the high risk of suicide for adults taking paroxetine, particularly in the early days of treatment. Read more
Judge Saylor denied GSK’s first Motion to Dismiss all of the pending Zofran cases on preemption grounds last year. Read more
Zofran is a powerful anti-nausea medication approved by the FDA for patients suffering from nausea as a side effect of chemotherapy. Read more
Zofran continues to be prescribed routinely for pregnant women suffering from morning sickness. Read more
The whistleblower suit was filed in New Jersey, contending the employee was fired for speaking out about unreliable study results that have underpinned the deceptive marketing of a smoking c... Read more
While the negotiated deal benefited Teva and GSK, the deal was not structured with any concern or interest for purchasers or consumers who need treatment for epilepsy, bipolar disorder, and... Read more
Despite knowing these risks, GSK claimed that Paxil was safer and more effective than other selective serotonin reuptake inhibitors, (SSRIs), on the market, and made marketing misrepresentat... Read more
GlaxoSmithKline PLC has been fined a record 3 billion yuan ($488.5 million) for bribing doctors. A verdict was handed down by a Chinese court, which also sentenced several of the drugmaker’s... Read more
GlaxoSmithKline PLC (GSK) has agreed in another settlement to pay $105 million to 44 states and the District of Columbia. This settlement resolves allegations that the company improperly mar... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.